What does DR. MARC SCHOUTEDEN do?

DR. MARC SCHOUTEDEN is a general practice in Hechtel-Eksel. Private Limited, started on 20 September 2002, 1 establishment.

What is the address of DR. MARC SCHOUTEDEN?

The registered office of DR. MARC SCHOUTEDEN is located at Stationsstraat 34, 3940 Hechtel-Eksel.

Is DR. MARC SCHOUTEDEN still active?

Yes. According to the CBE (31 October 2026) DR. MARC SCHOUTEDEN is active, legal situation “Normale toestand”, started on 20 September 2002.

Is DR. MARC SCHOUTEDEN registered on Peppol?

Yes, DR. MARC SCHOUTEDEN is registered on the Peppol network with ID 0208:0478390736.

What is the enterprise number of DR. MARC SCHOUTEDEN?

The enterprise number of DR. MARC SCHOUTEDEN is BE0478390736.

When was DR. MARC SCHOUTEDEN founded?

DR. MARC SCHOUTEDEN was founded on 20 September 2002.

Who are the directors of DR. MARC SCHOUTEDEN?

According to the 2025 annual accounts, the directors of DR. MARC SCHOUTEDEN are: Marc Schouteden.

Is DR. MARC SCHOUTEDEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 September 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. MARC SCHOUTEDEN make in 2025?

DR. MARC SCHOUTEDEN posted a profit after taxes of € 206,397 in financial year 2025.

What is the revenue of DR. MARC SCHOUTEDEN?

As a small company, DR. MARC SCHOUTEDEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 354,692.

DR. MARC SCHOUTEDEN (Private Limited) - Hechtel-Eksel

Dossier DR. MARC SCHOUTEDEN, printed on 1 November 2026 from databakkes.be/en/0478390736/dr-marc-schouteden. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. MARC SCHOUTEDEN from Hechtel-Eksel, company number BE0478390736, closed financial year 2025 with a result of € 206,397 after tax. For that financial year DR. MARC SCHOUTEDEN recorded a gross margin of € 354,692 and equity of € 795,064. Compared with financial year 2024, the result moved from € 201,326 to € 206,397. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What it is worth Growing

€ 795,064

▲ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 206,397

▲ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 388,456

▼ 20% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 81,339 paid out

39 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 41,168

▲ € 39,962 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,259

▼ 24% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 41,538

▲ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 275,456 Gross margin 2022: € 275,456 First fiscal year in the series	€ 256,727 Gross margin 2023: € 256,727 ▼ 7% vs 2022 (€ 275,456) Unfavourable step	€ 329,566 Gross margin 2024: € 329,566 ▲ 28% vs 2023 (€ 256,727) Favourable step	€ 354,692 Gross margin 2025: € 354,692 ▲ 8% vs 2024 (€ 329,566) Favourable step	▲ 8%
Profit after taxes	€ 144,881 Profit after taxes 2022: € 144,881 First fiscal year in the series	€ 136,328 Profit after taxes 2023: € 136,328 ▼ 6% vs 2022 (€ 144,881) Unfavourable step	€ 201,326 Profit after taxes 2024: € 201,326 ▲ 48% vs 2023 (€ 136,328) Favourable step	€ 206,397 Profit after taxes 2025: € 206,397 ▲ 3% vs 2024 (€ 201,326) Favourable step	▲ 3%
Equity	€ 1,228,559 Equity 2022: € 1,228,559 First fiscal year in the series	€ 575,479 Equity 2023: € 575,479 ▼ 53% vs 2022 (€ 1,228,559) Unfavourable step	€ 670,006 Equity 2024: € 670,006 ▲ 16% vs 2023 (€ 575,479) Favourable step	€ 795,064 Equity 2025: € 795,064 ▲ 19% vs 2024 (€ 670,006) Favourable step	▲ 19%
Total debts	€ 299,998 Total debts 2022: € 299,998 First fiscal year in the series	€ 837,834 Total debts 2023: € 837,834 ▲ 179% vs 2022 (€ 299,998) Unfavourable step	€ 195,461 Total debts 2024: € 195,461 ▼ 77% vs 2023 (€ 837,834) Favourable step	€ 270,875 Total debts 2025: € 270,875 ▲ 39% vs 2024 (€ 195,461) Unfavourable step	▲ 39%
Cash	€ 1,056,937 Cash 2022: € 1,056,937 First fiscal year in the series	€ 92,970 Cash 2023: € 92,970 ▼ 91% vs 2022 (€ 1,056,937) Unfavourable step	€ 488,353 Cash 2024: € 488,353 ▲ € 395,383 vs 2023 (€ 92,970) Favourable step	€ 388,456 Cash 2025: € 388,456 ▼ 20% vs 2024 (€ 488,353) Unfavourable step	▼ 20%
Land & buildings	€ 464,074 Land & buildings 2022: € 464,074 First fiscal year in the series	€ 409,186 Land & buildings 2023: € 409,186 ▼ 12% vs 2022 (€ 464,074) Unchanged	€ 361,344 Land & buildings 2024: € 361,344 ▼ 12% vs 2023 (€ 409,186) Unchanged	€ 308,718 Land & buildings 2025: € 308,718 ▼ 15% vs 2024 (€ 361,344) Unchanged	▼ 15%
Retained profit	€ 610,959 Retained profit 2022: € 610,959 First fiscal year in the series	€ 574,479 Retained profit 2023: € 574,479 ▼ 6% vs 2022 (€ 610,959) Unfavourable step	€ 669,006 Retained profit 2024: € 669,006 ▲ 16% vs 2023 (€ 574,479) Favourable step	€ 794,064 Retained profit 2025: € 794,064 ▲ 19% vs 2024 (€ 669,006) Favourable step	▲ 19%
Dividend	€ 49,264 Dividend 2022: € 49,264 First fiscal year in the series	€ 185,208 Dividend 2023: € 185,208 ▲ 276% vs 2022 (€ 49,264) Unchanged	€ 106,799 Dividend 2024: € 106,799 ▼ 42% vs 2023 (€ 185,208) Unchanged	€ 81,339 Dividend 2025: € 81,339 ▼ 24% vs 2024 (€ 106,799) Unchanged	▼ 24%
Balance sheet total	€ 1,528,557 Balance sheet total 2022: € 1,528,557 First fiscal year in the series	€ 1,413,312 Balance sheet total 2023: € 1,413,312 ▼ 8% vs 2022 (€ 1,528,557) Unchanged	€ 865,467 Balance sheet total 2024: € 865,467 ▼ 39% vs 2023 (€ 1,413,312) Unchanged	€ 1,065,940 Balance sheet total 2025: € 1,065,940 ▲ 23% vs 2024 (€ 865,467) Unchanged	▲ 23%

Key figures of DR. MARC SCHOUTEDEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. MARC SCHOUTEDEN?

What happened at DR. MARC SCHOUTEDEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 20, 2026 New annual accounts for financial year 2025: profit of € 206,397 (▲ 3% vs 2024). filed late Source: NBB ↗
2023 Marc Schouteden became a director. NBB
May 20, 2013 New establishment in Hechtel-Eksel. KBO
Sep 20, 2002 Start of the company according to the CBE. KBO

In short

From € 144,881 profit in 2022 to € 206,397 profit in 2025.

Paid € 306,054 in corporate taxes since 2022.

Best year ever: 2025, with € 206,397 profit.

Paid out € 422,609 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Marc Schouteden

DR. MARC SCHOUTEDEN

Behind DR. MARC SCHOUTEDEN is Marc Schouteden.

Directors

According to the 2025 annual accounts

Marc Schouteden

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Stationsstraat 34

3940 Hechtel-Eksel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0478.390.736
VAT number: BE 0478.390.736
Registered office: Stationsstraat 34, 3940 Hechtel-Eksel
Names & denominations: DR. MARC SCHOUTEDEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 September 2002
Peppol: Active · Active since 9 Dec 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗